Synonyms:
Status: Approved (2023)
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 09495UIM6V

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin 17A inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 3 D011565 ClinicalTrials
Arthritis, Psoriatic 3 D015535 ClinicalTrials
Spondylitis, Ankylosing 3 D013167 ClinicalTrials
Hidradenitis Suppurativa 3 D017497 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1418205-77-2
ChEMBL CHEMBL4297700
FDA SRS 09495UIM6V
Guide to Pharmacology 9411